Earnings calendar/FULC
Fulcrum Therapeutics, Inc. (FULC)
Pre-earnings consensus targets and post-earnings beat/miss — standardized metrics from the earnings calendar. No narrative, no price targets.
Pre-earnings
Consensus targets for the next print, plus how the business has been running.
Next report
Oct 29, 2026
Consensus estimate row
EPS target
$-0.13
Street estimate
Revenue target
—
Street estimate
Trailing EPS (avg 4Q)
$-0.28
Beat rate last 4: 75%
Latest EPS YoY
-21.4%
vs 2025-07-29
Latest revenue YoY
—
How results look so far
Trailing revenue (avg 4Q)
—
Printed quarters
EPS beat rate (4Q)
75%
Share of quarters that beat EPS est.
Post-earnings
Did the company hit the target? Actual vs estimate and surprise.
Last print
Jul 31, 2026
EPS miss
EPS actual / est
$-0.34 / $-0.24
-39.7%
Revenue actual / est
— / —
—
Result
Below target
Based on EPS vs consensus
Earnings history
Estimate vs actual and surprise % by print date
| Date | EPS est | EPS act | EPS surprise | Rev est | Rev act | Rev surprise |
|---|---|---|---|---|---|---|
| 10/29/2026upcoming | $-0.13 | Pending | — | — | Pending | — |
| 7/31/2026 | $-0.24 | $-0.34 | -39.7% | — | Pending | — |
| 7/30/2026 | $-0.24 | $-0.21 | +13.7% | — | Pending | — |
| 5/7/2026upcoming | $-0.31 | Pending | — | — | Pending | — |
| 4/27/2026 | $-0.31 | $-0.25 | +19.4% | — | Pending | — |
| 2/24/2026 | $-0.31 | $-0.31 | 0.0% | — | Pending | — |
| 10/29/2025 | $-0.29 | $-0.31 | -6.9% | — | Pending | — |
| 7/29/2025 | $-0.29 | $-0.28 | +3.4% | — | Pending | — |
| 5/1/2025 | $-0.29 | $-0.28 | +3.4% | — | Pending | — |
| 2/25/2025 | $-0.28 | $-0.31 | -10.7% | $142,857 | Pending | — |
| 11/13/2024 | $-0.40 | $-0.35 | +12.5% | $112,500 | Pending | — |
| 7/31/2024 | $-0.06 | $0.87 | +1550.0% | $14.8M | $80.0M | +439.9% |
| 5/13/2024 | $-0.44 | $-0.43 | +2.3% | $416,667 | Pending | — |
| 2/27/2024 | $-0.44 | $-0.40 | +9.1% | $552,718 | $871,000 | +57.6% |
| 11/7/2023 | $-0.44 | $-0.39 | +11.4% | $1.1M | $759,000 | -27.9% |
| 8/3/2023 | $-0.44 | $-0.38 | +13.6% | $1.1M | $880,000 | -21.1% |
| 6/23/2023 | — | $-0.45 | — | — | $685,000 | — |
| 5/15/2023 | $-0.47 | $-0.41 | +12.8% | $1.1M | $295,000 | -72.4% |
| 3/9/2023 | $-0.49 | $-0.50 | -2.0% | $1.9M | $685,000 | -63.8% |
| 11/8/2022 | $-0.62 | $-0.50 | +19.4% | $2.5M | $1.2M | -53.5% |
| 8/11/2022 | $-0.66 | $-0.83 | -25.8% | $3.0M | $1.9M | -36.5% |
| 5/9/2022 | $-0.63 | $-0.64 | -1.6% | $3.9M | $2.6M | -34.3% |
| 3/3/2022 | $-0.73 | $-0.58 | +20.3% | $2.7M | $5.1M | +88.7% |
| 11/4/2021 | $-0.64 | $-0.57 | +10.9% | $2.3M | $4.9M | +119.3% |
| 8/10/2021 | $-0.65 | $-0.60 | +7.7% | $1.6M | $4.4M | +173.8% |
| 5/6/2021 | $-0.66 | $-0.54 | +18.2% | $5.7M | $4.8M | -15.4% |
| 3/4/2021 | $-0.73 | $-0.64 | +12.3% | — | $4.2M | — |
| 11/10/2020 | $-0.66 | $-0.70 | -6.1% | $1.7M | $1.8M | +8.3% |
| 8/11/2020 | $-0.80 | $-0.66 | +17.5% | $2.4M | $2.0M | -15.4% |
| 5/13/2020 | $-0.75 | $-0.81 | -8.0% | $694,444.44 | $750,000 | +8.0% |
| 3/5/2020 | $-0.84 | $-0.71 | +15.5% | — | Pending | — |
| 11/14/2019 | $-0.62 | $-0.97 | -56.5% | — | Pending | — |
| 8/26/2019 | $-3.10 | $-9.21 | -197.1% | — | Pending | — |
| 3/31/2019 | — | $-1.58 | — | — | Pending | — |
| 12/31/2018 | — | $-0.52 | — | — | Pending | — |
| 9/30/2018 | — | $-0.53 | — | — | Pending | — |
| 6/30/2018 | — | $-0.46 | — | — | Pending | — |
| 3/31/2018 | — | $-0.41 | — | — | Pending | — |